ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $454,000 | -59.3% | 3,616 | -69.1% | 0.04% | -50.6% |
| Q2 2020 | $1,116,000 | +200.0% | 11,716 | +182.9% | 0.08% | +185.2% |
| Q1 2020 | $372,000 | +14.8% | 4,141 | -50.1% | 0.03% | +17.4% |
| Q1 2018 | $324,000 | +21.8% | 8,292 | +16.5% | 0.02% | -65.7% |
| Q3 2017 | $266,000 | -5.3% | 7,120 | -32.8% | 0.07% | +86.1% |
| Q1 2017 | $281,000 | -45.4% | 10,601 | -34.9% | 0.04% | -37.9% |
| Q2 2015 | $515,000 | – | 16,295 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |